 Julie Haines
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2019 | 678 | 2.360 |
Why?
| | Erythrocytes | 12 | 2019 | 700 | 1.850 |
Why?
| | Cysteine | 8 | 2019 | 204 | 1.550 |
Why?
| | Nitrogen Oxides | 6 | 2014 | 55 | 1.440 |
Why?
| | Blood Preservation | 9 | 2019 | 285 | 1.410 |
Why?
| | Metabolome | 11 | 2019 | 350 | 1.380 |
Why?
| | Oxidation-Reduction | 13 | 2019 | 1060 | 0.770 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 21 | 0.750 |
Why?
| | Phosphines | 4 | 2014 | 17 | 0.730 |
Why?
| | Peroxiredoxins | 3 | 2018 | 24 | 0.730 |
Why?
| | Sulfenic Acids | 3 | 2016 | 7 | 0.690 |
Why?
| | Hydrogen Peroxide | 3 | 2018 | 328 | 0.660 |
Why?
| | Proteins | 5 | 2016 | 1009 | 0.650 |
Why?
| | Mass Spectrometry | 7 | 2019 | 739 | 0.620 |
Why?
| | Eye Diseases, Hereditary | 1 | 2018 | 12 | 0.590 |
Why?
| | Erythrocyte Transfusion | 4 | 2019 | 194 | 0.580 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.560 |
Why?
| | Glycolysis | 7 | 2019 | 321 | 0.560 |
Why?
| | Retinal Detachment | 1 | 2018 | 63 | 0.550 |
Why?
| | Vitreous Body | 1 | 2018 | 110 | 0.550 |
Why?
| | Diabetic Retinopathy | 1 | 2018 | 189 | 0.500 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2019 | 201 | 0.490 |
Why?
| | Proteome | 2 | 2018 | 472 | 0.480 |
Why?
| | Chondrocytes | 2 | 2018 | 212 | 0.460 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2019 | 630 | 0.460 |
Why?
| | Blood Proteins | 1 | 2017 | 252 | 0.460 |
Why?
| | Neoplastic Stem Cells | 2 | 2019 | 399 | 0.450 |
Why?
| | Succinic Acid | 4 | 2018 | 37 | 0.450 |
Why?
| | Proteomics | 4 | 2018 | 1111 | 0.440 |
Why?
| | Plasma | 3 | 2019 | 212 | 0.420 |
Why?
| | Oxidative Phosphorylation | 3 | 2019 | 193 | 0.420 |
Why?
| | Extracellular Matrix | 1 | 2017 | 528 | 0.410 |
Why?
| | Triazenes | 1 | 2012 | 4 | 0.400 |
Why?
| | Oxidative Stress | 5 | 2019 | 1317 | 0.380 |
Why?
| | Cardiotonic Agents | 1 | 2012 | 124 | 0.380 |
Why?
| | Sulfones | 1 | 2012 | 110 | 0.370 |
Why?
| | Sulfhydryl Compounds | 2 | 2014 | 189 | 0.370 |
Why?
| | Lipids | 2 | 2019 | 672 | 0.370 |
Why?
| | Amino Acids | 3 | 2019 | 497 | 0.370 |
Why?
| | Shock, Hemorrhagic | 3 | 2018 | 167 | 0.350 |
Why?
| | Stomach Ulcer | 1 | 2011 | 14 | 0.350 |
Why?
| | Indomethacin | 1 | 2011 | 81 | 0.350 |
Why?
| | Macrophages | 3 | 2018 | 1547 | 0.340 |
Why?
| | Hydroxamic Acids | 1 | 2011 | 89 | 0.340 |
Why?
| | Prodrugs | 1 | 2011 | 52 | 0.340 |
Why?
| | Purines | 3 | 2018 | 176 | 0.330 |
Why?
| | Heart | 2 | 2019 | 655 | 0.330 |
Why?
| | Mitochondria | 3 | 2017 | 948 | 0.320 |
Why?
| | Energy Metabolism | 5 | 2019 | 922 | 0.320 |
Why?
| | Lipid Metabolism | 3 | 2019 | 518 | 0.320 |
Why?
| | Electron Transport Complex II | 1 | 2019 | 26 | 0.310 |
Why?
| | Animals | 25 | 2019 | 36940 | 0.300 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2018 | 18 | 0.300 |
Why?
| | Nitric Oxide | 2 | 2012 | 915 | 0.300 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 494 | 0.300 |
Why?
| | Organogenesis | 1 | 2019 | 58 | 0.290 |
Why?
| | Gluconates | 1 | 2018 | 5 | 0.290 |
Why?
| | Antacids | 1 | 2018 | 16 | 0.290 |
Why?
| | Lung | 3 | 2019 | 4060 | 0.290 |
Why?
| | Rejuvenation | 1 | 2018 | 19 | 0.290 |
Why?
| | Guanosine | 1 | 2018 | 41 | 0.290 |
Why?
| | Receptors, CCR2 | 1 | 2018 | 40 | 0.290 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 31 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 3 | 2018 | 465 | 0.280 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 350 | 0.280 |
Why?
| | Interleukin-1beta | 2 | 2018 | 372 | 0.280 |
Why?
| | Glycogen | 1 | 2017 | 55 | 0.280 |
Why?
| | Cryopreservation | 2 | 2018 | 100 | 0.270 |
Why?
| | Fatty Acids | 2 | 2019 | 443 | 0.270 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.270 |
Why?
| | Isotope Labeling | 2 | 2017 | 81 | 0.260 |
Why?
| | Reactive Oxygen Species | 6 | 2019 | 622 | 0.260 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 99 | 0.260 |
Why?
| | High-Throughput Screening Assays | 2 | 2019 | 158 | 0.260 |
Why?
| | Liver | 3 | 2018 | 1943 | 0.250 |
Why?
| | Wounds and Injuries | 3 | 2018 | 758 | 0.250 |
Why?
| | Iron | 1 | 2018 | 313 | 0.250 |
Why?
| | Calpain | 1 | 2016 | 59 | 0.240 |
Why?
| | Troponin T | 1 | 2016 | 65 | 0.240 |
Why?
| | Blood Pressure | 1 | 2012 | 1786 | 0.240 |
Why?
| | Humans | 38 | 2025 | 137585 | 0.240 |
Why?
| | src-Family Kinases | 1 | 2016 | 92 | 0.230 |
Why?
| | Cholestasis | 1 | 2018 | 235 | 0.230 |
Why?
| | Temperature | 1 | 2018 | 679 | 0.230 |
Why?
| | Calcium Channels, L-Type | 1 | 2016 | 118 | 0.230 |
Why?
| | Cycloparaffins | 1 | 2014 | 2 | 0.220 |
Why?
| | Bridged Bicyclo Compounds | 1 | 2014 | 12 | 0.220 |
Why?
| | Fetus | 1 | 2019 | 806 | 0.220 |
Why?
| | Acute Lung Injury | 1 | 2017 | 287 | 0.220 |
Why?
| | Kynurenine | 1 | 2025 | 114 | 0.220 |
Why?
| | Dendritic Cells | 1 | 2017 | 483 | 0.220 |
Why?
| | NF-kappa B | 1 | 2018 | 691 | 0.220 |
Why?
| | Cells | 1 | 2014 | 25 | 0.210 |
Why?
| | Peptide Fragments | 2 | 2016 | 706 | 0.210 |
Why?
| | Dithiothreitol | 1 | 2013 | 17 | 0.210 |
Why?
| | Biomarkers | 6 | 2025 | 4149 | 0.210 |
Why?
| | Osteoarthritis | 1 | 2016 | 185 | 0.210 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2014 | 180 | 0.200 |
Why?
| | Nucleic Acids | 1 | 2014 | 71 | 0.200 |
Why?
| | Fluorescent Dyes | 1 | 2014 | 321 | 0.200 |
Why?
| | Cartilage, Articular | 1 | 2016 | 311 | 0.190 |
Why?
| | Glucose | 2 | 2018 | 1020 | 0.190 |
Why?
| | DNA Damage | 1 | 2014 | 420 | 0.180 |
Why?
| | Oxidants | 2 | 2019 | 111 | 0.170 |
Why?
| | Biomedical Research | 1 | 2017 | 692 | 0.170 |
Why?
| | Disease Models, Animal | 7 | 2019 | 4295 | 0.170 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 570 | 0.170 |
Why?
| | Mice | 11 | 2019 | 17787 | 0.170 |
Why?
| | S-Nitrosothiols | 1 | 2010 | 5 | 0.170 |
Why?
| | S-Nitrosoglutathione | 1 | 2010 | 8 | 0.170 |
Why?
| | Hemeproteins | 1 | 2010 | 8 | 0.170 |
Why?
| | Molecular Structure | 3 | 2012 | 489 | 0.170 |
Why?
| | Models, Biological | 1 | 2017 | 1783 | 0.160 |
Why?
| | Biocatalysis | 2 | 2014 | 56 | 0.160 |
Why?
| | Kinetics | 3 | 2014 | 1670 | 0.160 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 5757 | 0.160 |
Why?
| | Leukopoiesis | 1 | 2019 | 11 | 0.160 |
Why?
| | NADPH Oxidase 2 | 1 | 2019 | 39 | 0.150 |
Why?
| | Myeloid Progenitor Cells | 1 | 2019 | 17 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 14 | 0.150 |
Why?
| | Cardio-Renal Syndrome | 1 | 2019 | 12 | 0.150 |
Why?
| | Heart Failure, Diastolic | 1 | 2019 | 21 | 0.150 |
Why?
| | Cell Self Renewal | 1 | 2019 | 56 | 0.150 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2014 | 144 | 0.150 |
Why?
| | Asparagine | 1 | 2018 | 31 | 0.150 |
Why?
| | Xanthine | 1 | 2018 | 7 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 79 | 0.150 |
Why?
| | Blood Banks | 1 | 2018 | 41 | 0.150 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 183 | 0.150 |
Why?
| | Arousal | 1 | 2019 | 155 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 29 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.140 |
Why?
| | Methods | 1 | 2017 | 65 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.140 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 19 | 0.140 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.140 |
Why?
| | Benzeneacetamides | 1 | 2017 | 7 | 0.140 |
Why?
| | Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 17 | 0.140 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.140 |
Why?
| | Polypyrimidine Tract-Binding Protein | 1 | 2017 | 17 | 0.140 |
Why?
| | Benzothiazoles | 1 | 2017 | 33 | 0.140 |
Why?
| | Pyruvate Kinase | 1 | 2017 | 29 | 0.140 |
Why?
| | Thiadiazoles | 1 | 2017 | 23 | 0.140 |
Why?
| | Sciuridae | 1 | 2019 | 147 | 0.140 |
Why?
| | Sphingosine | 1 | 2017 | 46 | 0.140 |
Why?
| | Aging | 2 | 2018 | 1864 | 0.140 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2017 | 48 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2017 | 80 | 0.130 |
Why?
| | Solubility | 1 | 2017 | 245 | 0.130 |
Why?
| | Rabbits | 2 | 2019 | 794 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 88 | 0.130 |
Why?
| | Phenylurea Compounds | 1 | 2017 | 97 | 0.130 |
Why?
| | Time Factors | 5 | 2025 | 6828 | 0.130 |
Why?
| | Models, Molecular | 3 | 2018 | 1570 | 0.130 |
Why?
| | Signal Transduction | 4 | 2018 | 5079 | 0.130 |
Why?
| | Leukemia | 1 | 2019 | 240 | 0.130 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 2 | 2016 | 532 | 0.130 |
Why?
| | Fibronectins | 2 | 2018 | 133 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 41 | 0.130 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 153 | 0.130 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 345 | 0.130 |
Why?
| | Lactic Acid | 1 | 2018 | 305 | 0.130 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2018 | 597 | 0.130 |
Why?
| | Stroke | 1 | 2025 | 1120 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2018 | 279 | 0.120 |
Why?
| | Adenosine Triphosphate | 2 | 2019 | 491 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 121 | 0.120 |
Why?
| | Apolipoproteins | 1 | 2015 | 33 | 0.120 |
Why?
| | Esters | 2 | 2011 | 76 | 0.120 |
Why?
| | Muscle, Skeletal | 1 | 2016 | 1724 | 0.120 |
Why?
| | Ischemia | 1 | 2019 | 409 | 0.120 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 77 | 0.120 |
Why?
| | Workflow | 1 | 2017 | 165 | 0.120 |
Why?
| | Chromatography, Liquid | 2 | 2019 | 433 | 0.120 |
Why?
| | Inflammation Mediators | 2 | 2019 | 513 | 0.120 |
Why?
| | Cyclohexanones | 2 | 2016 | 9 | 0.120 |
Why?
| | Protein Stability | 2 | 2016 | 176 | 0.110 |
Why?
| | Healthy Volunteers | 2 | 2019 | 199 | 0.110 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2018 | 32 | 0.110 |
Why?
| | Peroxiredoxin III | 1 | 2013 | 1 | 0.110 |
Why?
| | Anemia, Sickle Cell | 1 | 2017 | 270 | 0.110 |
Why?
| | Sulfinic Acids | 1 | 2013 | 7 | 0.110 |
Why?
| | Amino Acid Sequence | 2 | 2018 | 2139 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2486 | 0.100 |
Why?
| | Sulfonamides | 2 | 2018 | 513 | 0.100 |
Why?
| | Nitrogen Isotopes | 2 | 2017 | 72 | 0.100 |
Why?
| | Disulfides | 1 | 2013 | 107 | 0.100 |
Why?
| | Carbon Isotopes | 2 | 2017 | 144 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 385 | 0.100 |
Why?
| | Half-Life | 1 | 2012 | 164 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 528 | 0.100 |
Why?
| | Female | 12 | 2025 | 73304 | 0.090 |
Why?
| | Enzyme Activation | 1 | 2013 | 810 | 0.090 |
Why?
| | Swine | 3 | 2018 | 775 | 0.090 |
Why?
| | Carrageenan | 1 | 2011 | 8 | 0.090 |
Why?
| | Critical Illness | 1 | 2017 | 811 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2017 | 611 | 0.090 |
Why?
| | Naproxen | 1 | 2011 | 17 | 0.090 |
Why?
| | Gastric Mucosa | 1 | 2011 | 55 | 0.090 |
Why?
| | Stereoisomerism | 1 | 2011 | 96 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2019 | 815 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2011 | 79 | 0.090 |
Why?
| | MicroRNAs | 1 | 2017 | 692 | 0.090 |
Why?
| | Tryptophan | 2 | 2025 | 183 | 0.090 |
Why?
| | Male | 12 | 2025 | 67762 | 0.090 |
Why?
| | Ibuprofen | 1 | 2011 | 84 | 0.080 |
Why?
| | Rats | 3 | 2018 | 5647 | 0.080 |
Why?
| | Cells, Cultured | 3 | 2019 | 4193 | 0.080 |
Why?
| | Hypoxia | 1 | 2017 | 1112 | 0.080 |
Why?
| | Edema | 1 | 2011 | 130 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1096 | 0.080 |
Why?
| | Plasticizers | 1 | 2019 | 15 | 0.080 |
Why?
| | Cell Line | 2 | 2016 | 2847 | 0.080 |
Why?
| | Succinate Dehydrogenase | 1 | 2019 | 50 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2900 | 0.070 |
Why?
| | Caspases, Initiator | 1 | 2018 | 17 | 0.070 |
Why?
| | Liver X Receptors | 1 | 2018 | 31 | 0.070 |
Why?
| | Multidrug Resistance-Associated Proteins | 1 | 2018 | 38 | 0.070 |
Why?
| | Vasoconstrictor Agents | 1 | 2019 | 139 | 0.070 |
Why?
| | Pulmonary Surfactants | 1 | 2019 | 106 | 0.070 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 238 | 0.070 |
Why?
| | Organ Size | 1 | 2019 | 477 | 0.070 |
Why?
| | Methionine | 1 | 2018 | 160 | 0.070 |
Why?
| | Glycogen Phosphorylase | 1 | 2017 | 4 | 0.070 |
Why?
| | Solutions | 1 | 2018 | 168 | 0.070 |
Why?
| | Caspase 1 | 1 | 2018 | 144 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 233 | 0.070 |
Why?
| | Azacitidine | 1 | 2018 | 140 | 0.070 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 187 | 0.070 |
Why?
| | Biological Transport | 1 | 2018 | 418 | 0.070 |
Why?
| | Cell Respiration | 1 | 2017 | 103 | 0.070 |
Why?
| | Glutathione | 1 | 2019 | 356 | 0.070 |
Why?
| | Trachea | 1 | 2019 | 237 | 0.070 |
Why?
| | Receptors, Interleukin-1 | 1 | 2018 | 216 | 0.070 |
Why?
| | Immune System | 1 | 2018 | 177 | 0.070 |
Why?
| | Hemoglobins | 2 | 2018 | 353 | 0.070 |
Why?
| | Caspases | 1 | 2018 | 247 | 0.070 |
Why?
| | Lipoproteins | 1 | 2018 | 168 | 0.070 |
Why?
| | Parenteral Nutrition | 1 | 2018 | 107 | 0.070 |
Why?
| | Mutation | 2 | 2013 | 3958 | 0.070 |
Why?
| | Hepatocytes | 1 | 2018 | 220 | 0.070 |
Why?
| | Immunologic Factors | 1 | 2019 | 236 | 0.070 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 227 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2018 | 1092 | 0.060 |
Why?
| | Glutamine | 2 | 2017 | 103 | 0.060 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2016 | 15 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 220 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3412 | 0.060 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2016 | 17 | 0.060 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2016 | 24 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1910 | 0.060 |
Why?
| | History, Ancient | 1 | 2016 | 54 | 0.060 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2016 | 86 | 0.060 |
Why?
| | Pregnancy | 2 | 2019 | 6763 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2018 | 1316 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2017 | 2475 | 0.060 |
Why?
| | Cell Lineage | 1 | 2017 | 350 | 0.060 |
Why?
| | Immunoblotting | 1 | 2016 | 308 | 0.060 |
Why?
| | Inflammation | 1 | 2016 | 2837 | 0.060 |
Why?
| | Vasodilation | 1 | 2018 | 499 | 0.060 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 327 | 0.060 |
Why?
| | Muscle Fatigue | 1 | 2016 | 102 | 0.060 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1509 | 0.060 |
Why?
| | Cytokines | 2 | 2017 | 2085 | 0.060 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 452 | 0.060 |
Why?
| | Microscopy, Confocal | 1 | 2016 | 325 | 0.060 |
Why?
| | Homeostasis | 1 | 2018 | 621 | 0.060 |
Why?
| | Peptide Mapping | 1 | 2014 | 64 | 0.060 |
Why?
| | Molecular Probes | 1 | 2014 | 36 | 0.060 |
Why?
| | Cell Survival | 1 | 2017 | 1120 | 0.050 |
Why?
| | Iodoacetamide | 1 | 2013 | 5 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2016 | 188 | 0.050 |
Why?
| | Ethylmaleimide | 1 | 2013 | 18 | 0.050 |
Why?
| | Methyl Methanesulfonate | 1 | 2013 | 7 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2014 | 80 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 886 | 0.050 |
Why?
| | Oxygen | 1 | 2018 | 931 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7635 | 0.050 |
Why?
| | HeLa Cells | 1 | 2014 | 636 | 0.050 |
Why?
| | Hypoglycemia | 1 | 2017 | 445 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 620 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 810 | 0.050 |
Why?
| | Myocardium | 2 | 2019 | 1002 | 0.050 |
Why?
| | Adult | 5 | 2019 | 37929 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2017 | 2167 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2013 | 177 | 0.050 |
Why?
| | Up-Regulation | 1 | 2025 | 843 | 0.050 |
Why?
| | Pneumonia | 1 | 2017 | 639 | 0.050 |
Why?
| | Colorado | 2 | 2025 | 4565 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1250 | 0.040 |
Why?
| | Microbiota | 1 | 2018 | 762 | 0.040 |
Why?
| | Nitrosation | 1 | 2010 | 8 | 0.040 |
Why?
| | Horseradish Peroxidase | 1 | 2010 | 28 | 0.040 |
Why?
| | Myoglobin | 1 | 2010 | 13 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1774 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2057 | 0.040 |
Why?
| | Guanylate Cyclase | 1 | 2010 | 37 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2010 | 60 | 0.040 |
Why?
| | Catalase | 1 | 2010 | 130 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2017 | 1991 | 0.040 |
Why?
| | Protein Binding | 1 | 2016 | 2224 | 0.040 |
Why?
| | Aza Compounds | 1 | 2009 | 14 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1457 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3284 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 155 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 10 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 10 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 30 | 0.040 |
Why?
| | Erythrocyte Deformability | 1 | 2018 | 19 | 0.040 |
Why?
| | Sulfur | 1 | 2019 | 58 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2607 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 94 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2018 | 201 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 194 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2019 | 191 | 0.040 |
Why?
| | Hibernation | 1 | 2019 | 75 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 230 | 0.040 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2016 | 3556 | 0.040 |
Why?
| | Antagomirs | 1 | 2017 | 12 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2017 | 19 | 0.040 |
Why?
| | Water | 1 | 2011 | 460 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2018 | 132 | 0.040 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2018 | 225 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 12 | 0.030 |
Why?
| | Pentose Phosphate Pathway | 1 | 2017 | 53 | 0.030 |
Why?
| | Freezing | 1 | 2017 | 90 | 0.030 |
Why?
| | Lactates | 1 | 2017 | 85 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 82 | 0.030 |
Why?
| | Reference Standards | 1 | 2017 | 186 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 2129 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2018 | 466 | 0.030 |
Why?
| | Primates | 1 | 2018 | 126 | 0.030 |
Why?
| | Mice, Nude | 1 | 2018 | 698 | 0.030 |
Why?
| | Chemical Fractionation | 1 | 2016 | 26 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 76 | 0.030 |
Why?
| | Middle Aged | 3 | 2025 | 33479 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2017 | 180 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2018 | 476 | 0.030 |
Why?
| | Risk Factors | 2 | 2025 | 10388 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 23 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 280 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2018 | 6079 | 0.030 |
Why?
| | Databases, Protein | 1 | 2016 | 85 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 730 | 0.030 |
Why?
| | Hemolysis | 1 | 2017 | 206 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 98 | 0.030 |
Why?
| | Apolipoprotein L1 | 1 | 2015 | 14 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 135 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2017 | 404 | 0.030 |
Why?
| | Proteolysis | 1 | 2016 | 177 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3566 | 0.030 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2017 | 210 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 642 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 601 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 469 | 0.030 |
Why?
| | Aged | 2 | 2025 | 23961 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2017 | 229 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 246 | 0.030 |
Why?
| | Risk Assessment | 1 | 2025 | 3457 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 984 | 0.030 |
Why?
| | Trauma Centers | 1 | 2017 | 421 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 872 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 357 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2015 | 377 | 0.030 |
Why?
| | Fibroblasts | 1 | 2017 | 996 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2031 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2015 | 408 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 927 | 0.020 |
Why?
| | Kidney | 1 | 2019 | 1468 | 0.020 |
Why?
| | Peptides | 1 | 2016 | 985 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 991 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3196 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 4030 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2015 | 2426 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2668 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 2111 | 0.010 |
Why?
|
|
Haines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|